Compensation for research related injury.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Capacity for ethical and regulatory review of herbal trials in developing countries: a case study of Moringa oleifera research in HIV-infected patients.Journal of pharmaceutical policy and practice · 2017
   Article
2. The revised Declaration of Helsinki: cosmetic or real change?Journal of the Royal Society of Medicine · 2016
   Review
3. Compensation for clinical trial-related injury and death in India: challenges and the way forward.Drug safety · 2014
   Article
4. Clinical Research Environment in India: Challenges and Proposed Solutions.Journal of clinical research & bioethics · 2014
   Article
5. Insurance in clinical research.Perspectives in clinical research · 2014
   Article
6. Ethics Standards (HRPP) and Public Partnership (PARTAKE) to Address Clinical Research Concerns in India: Moving Toward Ethical, Responsible, Culturally Sensitive, and Community-Engaging Clinical Research.Journal of clinical research & bioethics · 2014
   Article
7. High rate of awarding compensation for claims of injuries related to clinical trials by pharmaceutical companies in Japan: a questionnaire survey.PloS one · 2014
   Article
8. Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India.Perspectives in clinical research
   Article
9. Evaluation of factors that act as barriers in conducting academic trials - An investigator's perception.Perspectives in clinical research
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.